66.24 F
New York
September 18, 2019
Home » Health / Medicine

Health / Medicine

Reuters - Business

U.S. Senators urge FTC to scrutinize multi-billion dollar pharma mergers

Reuters
FILE PHOTO: Democratic U.S. presidential candidate Senator Amy Klobuchar speaks at the 2019 Presidential Galivants Ferry Stump Meeting in Galivants Ferry, South Carolina, U.S. September
Reuters - Business

Factbox: Britain’s insulin providers prepare for Brexit fallout

Reuters
Georgina poses for a photograph with her insulin medical supplies in London, Britain September 13, 2019.REUTERS/Simon Dawson LONDON (Reuters) – With Britain sourcing the vast
Reuters - Business

With a backup to the backup, insulin makers say they’re primed for Brexit

Reuters
LONDON (Reuters) – For two men trained as scientists, the bosses of Britain’s major insulin providers have had to become experts in ferry schedules, trucking
Reuters - Business

Factbox: What’s next for OxyContin maker Purdue Pharma

Reuters
(Reuters) – OxyContin maker Purdue Pharma LP filed for bankruptcy protection after reaching a partial deal to resolve more than 2,600 lawsuits alleging it helped
Reuters - Business

OxyContin maker Purdue Pharma files for bankruptcy protection

Reuters
NEW YORK (Reuters) – OxyContin maker Purdue Pharma LP filed for bankruptcy protection in New York Sunday night, succumbing to pressure from more than 2,000
Reuters - Business

Companies ask judge in U.S. opioid trial to recuse himself

Reuters
WASHINGTON (Reuters) – Major drug wholesalers and retailers facing a massive lawsuit for allegedly fostering the nation’s opioid crisis asked the judge hearing the case
Reuters - Business

Amid U.S. vaping crackdown, Juul enters China with online store openings

Reuters
SHANGHAI (Reuters) – U.S. e-cigarettes maker Juul Labs Inc, which faces a widening crackdown on vaping at home, has entered China, with online storefronts on
Reuters - Business

Factbox: Purdue OxyContin settlement would rank among largest in pharma history

Reuters
(Reuters) – OxyContin maker Purdue Pharma LP is nearing a multibillion-dollar partial agreement aimed at settling thousands of lawsuits over its alleged role in the
Reuters - Business

Exclusive: Purdue Pharma nears partial opioid settlement, bankruptcy filing – sources

Reuters
NEW YORK (Reuters) – OxyContin maker Purdue Pharma LP is nearing a partial agreement to resolve widespread litigation over its alleged role in fueling the
Reuters - Business

More Americans went without health insurance in 2018; income growth stalled

Reuters
WASHINGTON (Reuters) – The share of Americans without health insurance rose for the first time in a decade last year and U.S. household income barely
Reuters - Business

Novartis CEO promises to speed data integrity disclosures

Reuters
FILE PHOTO: CEO Vas Narasimhan of Swiss drugmaker Novartis addresses the company’s annual news conference in Basel, Switzerland January 30, 2019. REUTERS/Arnd Wiegmann/File Photo ZURICH
Reuters - Business

Roche CEO touts drugs pipeline, rules out M&A just to boost sales

Reuters
BASEL, Switzerland (Reuters) – Swiss drugmaker Roche (ROG.S) sees medicines in its own pipeline driving sales growth over the longer term, Chief Executive Severin Schwan
Reuters - Business

Roche doesn’t need M&A to boost sales, sees growth from own meds: CEO

Reuters
BASEL, Switzerland (Reuters) – Swiss drugmaker Roche (ROG.S) sees sales rising in the longer term from medicines in its own pipeline, Chief Executive Severin Schwan
Reuters - Business

Exclusive: OxyContin maker prepares ‘free-fall’ bankruptcy as settlement talks stall

Reuters
(Reuters) – OxyContin maker Purdue Pharma LP is preparing to seek bankruptcy protection before the end of the month if it does not reach a
Reuters - Business

FTC probes marketing practices of e-cigarette maker Juul: source

Reuters
WASHINGTON (Reuters) – The Federal Trade Commission is investigating the marketing practices of e-cigarette maker Juul Labs Inc sending shares of tobacco stocks down, a
Reuters - Business

U.S. judge rules for Regeneron, Sanofi in Amgen cholesterol drug patent fight

Reuters
FILE PHOTO: A logo of Sanofi is pictured during the company’s shareholder meeting in Paris, France, April 30, 2019. REUTERS/Benoit Tessier/File Photo (Reuters) – A
Reuters - Business

Purdue Pharma in discussion on $10 billion-$12 billion offer to settle opioid lawsuits: sources

Reuters
(Reuters) – OxyContin maker Purdue Pharma LP and its owners, the Sackler family, are in discussion to settle more than 2,000 opioid lawsuits against the
Reuters - Business

Purdue Pharma in discussion on $10 billion-$12 billion offer to settle opioid claims: sources

Reuters
(Reuters) – OxyContin maker Purdue Pharma and its owners, the Sackler family, is in discussion to settle more than 2,000 lawsuits against the company for
Reuters - Business

J&J liable for $572 million in Oklahoma opioid epidemic trial, shares rise

Reuters
NORMAN, Okla. (Reuters) – An Oklahoma judge on Monday ordered Johnson & Johnson (JNJ.N) to pay $572.1 million to the state for its part in
Reuters - Business

Factbox: Oklahoma judge finds J&J liable in first trial over opioids

Reuters
(Reuters) – An Oklahoma judge on Monday ruled that Johnson & Johnson (JNJ.N) was liable for its part in fueling the opioid epidemic and ordered

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Click whichever is suitable. Accept Read More